Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...
Founded by Dr. Thomas Crisman, Genome Based Diagnostics has focused on developing accessible and reliable testing solutions ...
Shares in Advanced Micro Devices (AMD) were up 2.2% in pre-market trading on Monday, extending gains from Friday's session, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback